BlackRock’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-34,910
| Closed | -$24.8K | – | 5646 |
|
|
2023
Q2 | $24.8K | Hold |
34,910
| – | – | ﹤0.01% | 5179 |
|
|
2023
Q1 | $42.2K | Hold |
34,910
| – | – | ﹤0.01% | 5150 |
|
|
2022
Q4 | $29K | Buy |
34,910
+2
| +0% | +$2 | ﹤0.01% | 5331 |
|
|
2022
Q3 | $47K | Hold |
34,908
| – | – | ﹤0.01% | 5377 |
|
|
2022
Q2 | $79K | Sell |
34,908
-4
| -0% | -$14 | ﹤0.01% | 5304 |
|
|
2022
Q1 | $174K | Hold |
34,912
| – | – | ﹤0.01% | 5140 |
|
|
2021
Q4 | $232K | Hold |
34,912
| – | – | ﹤0.01% | 5079 |
|
|
2021
Q3 | $529K | Buy |
34,912
+502
| +1% | +$8.5K | ﹤0.01% | 4741 |
|
|
2021
Q2 | $750K | Sell |
34,410
-8,527
| -20% | -$177K | ﹤0.01% | 4595 |
|
|
2021
Q1 | $1.12M | Buy |
42,937
+39,712
| +1,231% | +$997K | ﹤0.01% | 4467 |
|
|
2020
Q4 | $49K | Hold |
3,225
| – | – | ﹤0.01% | 4675 |
|
|
2020
Q3 | $106K | Hold |
3,225
| – | – | ﹤0.01% | 4502 |
|
|
2020
Q2 | $246K | Sell |
3,225
-3
| -0.1% | -$252 | ﹤0.01% | 4337 |
|
|
2020
Q1 | $200K | Buy |
3,228
+6
| +0.2% | +$468 | ﹤0.01% | 4227 |
|
|
2019
Q4 | $258K | Sell |
3,222
-2,518
| -44% | -$177K | ﹤0.01% | 4287 |
|
|
2019
Q3 | $363K | Sell |
5,740
-1,615
| -22% | -$105K | ﹤0.01% | 4223 |
|
|
2019
Q2 | $383K | Sell |
7,355
-458
| -6% | -$79.5K | ﹤0.01% | 4239 |
|
|
2019
Q1 | $1.69M | Sell |
7,813
-247
| -3% | -$99.6K | ﹤0.01% | 3761 |
|
|
2018
Q4 | $2.79M | Sell |
8,060
-60
| -0.7% | -$46.6K | ﹤0.01% | 3572 |
|
|
2018
Q3 | $9.42M | Buy |
8,120
+957
| +13% | +$882K | ﹤0.01% | 3259 |
|
|
2018
Q2 | $6.13M | Sell |
7,163
-4,421
| -38% | -$3.67M | ﹤0.01% | 3448 |
|
|
2018
Q1 | $13.6M | Buy |
11,584
+3,617
| +45% | +$4M | ﹤0.01% | 2968 |
|
|
2017
Q4 | $7.36M | Buy |
7,967
+465
| +6% | +$429K | ﹤0.01% | 3288 |
|
|
2017
Q3 | $8.24M | Buy |
7,502
+170
| +2% | +$193K | ﹤0.01% | 3275 |
|
|
2017
Q2 | $8.45M | Buy |
7,332
+6,486
| +767% | +$7.9M | ﹤0.01% | 3261 |
|
|
2017
Q1 | $977K | Buy |
846
+836
| +8,360% | +$807K | ﹤0.01% | 3819 |
|
|
2016
Q4 | $11K | Buy |
+10
| New | +$4.54K | ﹤0.01% | 3381 |
|
Other funds holding HSTO
SF
GRP
CLOS
BlackRock's HSTO Position: Q3 2023 in Review
BlackRock sold out of Histogen Inc. Common Stock (HSTO) in Q3 2023, closing a stake of 34,910 shares — an estimated $24.8K sold.
BlackRock first reported a position in HSTO in Q4 2016 and held it in 27 quarters. The position peaked at $13.6M in Q1 2018. 9 funds tracked by Wall St. Rank hold HSTO as of Q3 2023.
- BlackRock reported no remaining Histogen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- BlackRock sold 34,910 Histogen Inc. Common Stock shares in Q3 2023, an estimated $24.8K.
- BlackRock first reported a position in Histogen Inc. Common Stock in Q4 2016 and held it in 27 quarters.
- BlackRock's Histogen Inc. Common Stock position peaked at $13.6M in Q1 2018.
- 9 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2023.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.